Related Experiment Video
Updated: Jul 14, 2025

Author Spotlight: Identification and Isolation of Quiescent Leukemia Stem Cells from Zebrafish T-ALL
Published on: July 19, 2024
A simplified prognostic score for T-cell large granular lymphocyte leukaemia
Hailing Liu1, Jingjing Guo2, Lei Cao1
1Department of Hematology, Jiangsu Province Hospital and Nanjing Medical University First Affiliated Hospital, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing, China.
This study identifies key factors for predicting survival in T-cell large granular lymphocyte leukaemia (T-LGLL). A new predictive model aids in guiding treatment decisions for T-LGLL patients, improving outcomes.
Area of Science:
- Hematology
- Oncology
- Clinical Prediction Modeling
Background:
- T-cell large granular lymphocyte leukaemia (T-LGLL) typically has a favorable prognosis.
- A subset of T-LGLL patients experiences significantly shorter survival times.
- Identifying prognostic factors is crucial for effective therapeutic strategies.
Purpose of the Study:
- To identify clinical factors associated with overall survival (OS) in T-LGLL patients.
- To develop a predictive model for OS in T-LGLL.
- To guide therapeutic decision-making for T-LGLL management.
Main Methods:
- Retrospective analysis of 120 T-LGLL patients.
- Lasso regression for feature selection.
- Univariate and multivariate Cox regression analyses.
- Decision tree algorithm for OS prediction model construction.
Main Results:
- Median follow-up was 75 months; 5-year OS rate was 82.2%, 10-year OS rate was 63.8%.
- Poor Eastern Cooperative Oncology Group performance status (≥2) and low platelet count (<100 × 10^9/L) independently predicted worse OS.
- A validated decision tree model stratified patients into low, intermediate, and high-risk groups with distinct survival outcomes.
- Conventional immunosuppressive therapy was insufficient for high-risk T-LGLL patients.
Conclusions:
- A simplified, clinically applicable scoring system for predicting OS in T-LGLL has been developed.
- The model effectively predicts survival outcomes in T-LGLL.
- External validation is recommended prior to widespread clinical implementation.
More Related Videos
10:18From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia
Published on: October 19, 2014
09:01Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
Published on: March 26, 2018